이 에피소드에 관해
In this episode of The Connect Current, host James Zanewicz sits down with Debbie Chen, Founder and CEO of Hydrostasis, to explore how nontraditional journeys are shaping the next generation of innovation.
Debbie shares how Hydrostasis is advancing hydration science through wearable technology, and why better understanding hydration as a vital sign could unlock new opportunities in health and performance. She also reflects on her own path into entrepreneurship and what it means to build from outside the traditional mold.
This conversation is a thoughtful look at how lived experience, access, and perspective are expanding who gets to innovate and what gets built next in San Diego and beyond.
Debbie shares how Hydrostasis is advancing hydration science through wearable technology, and why better understanding hydration as a vital sign could unlock new opportunities in health and performance. She also reflects on her own path into entrepreneurship and what it means to build from outside the traditional mold.
This conversation is a thoughtful look at how lived experience, access, and perspective are expanding who gets to innovate and what gets built next in San Diego and beyond.
영어
미국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
In this episode of The Connect Current, we sit down with Graeme Rae, Ph.D., Founder and CEO of HyperKelp, to explore how the company is turning the ocean into a sensing network. Graeme shares how HyperKelp’s Kelp Smart Buoy is designed as an open marine platform that can carry a wide range of senso…
In this episode of The Connect Current, we sit down with Ramesh Ramji, Founder and CEO of SpectralTx, to explore how spectral hyperplexing technology could help reshape molecular screening and the future of connected data. Ramesh shares how SpectralTx is developing tools like Spectra-Gel and SpELs …
In this episode of The Connect Current, we sit down with Stanley Lewis, MD, MPH, Founder and CEO of A28 Therapeutics, to explore how targeted cancer therapies can create better options for patients facing difficult diseases. Stanley shares the story behind A28’s targeted oncolytic peptide platform,…
In this episode of The Connect Current, we sit down with James Mackay, Ph.D., President and CEO of Crystalys Therapeutics, to explore how the company is advancing a new treatment path for people living with gout. James shares how Crystalys is developing dotinurad, a next-generation, once-daily oral…
In this episode of The Connect Current, we sit down with Niren Shah, PharmD, MBA, Co-founder and CEO of Cove Therapeutics, to explore one of the biggest challenges in genetic medicine: delivery. Niren shares how Cove is developing non-lipid, non-viral biodegradable polymeric nanoparticles designed …
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Connect에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
